• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND COMPLETE SE ILIAC; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND COMPLETE SE ILIAC; STENT, ILIAC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Occlusion (1984); Injury (2348); Aortic Dissection (2491); Vascular Dissection (3160)
Event Date 12/02/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted that documented a study where off-shelf devices were used for treatment of thoracic aortic diseases.Retrospective analysis was conducted of 474 consecutive patients treated with either fenestration tevar (f-tevar) or chimney tevar (ch-tevar).The complete se stents were only implanted in patients in the f-tevar group.The primary endpoints at 30 days and during follow up were overall mortality, aorta-related mortality, and major complications.The secondary endpoints were endoleak and reintervention.It was reported that 4 patients died within 30 days of procedures.One patient with tad suffered a retrograde dissection which resulted in death on the third day.Of the three deaths among the 364 ch-tevar patients, one was due to cerebral infarction 3 days post procedure, another to retrograde dissection at 2 days and third to myocardial infaction 4 days post tevar.Perioperative cerebral ischemia occurred in nine patients: 1 f-tevar patient had a tia with full recovery in follow up vs 7tias in ch-tevar group (all treated and discharged), in addition to the fatal stroke noted above.Two f-tevar patients died of retrograde dissection at 8 and 16 months in addition to the one in hospital.In the ch-tevar group, 7 patients died at follow up in addition to the fatal retrograde dissection in hospital.Of these 7 late deaths, 2 were sudden deaths after complaining about chest tightness and uncontrollable hypertension that was believed to be related to tad.One patient died of acute cerebral infarction, 3 patients died of retrograde dissection af ter open surgery, and one patient died of pulmonary infection subsequent to paraplegia.During entire follow up period, 22 patients suffered cerebral ischemia (4 in f-tevar group and 18 in the ch-tevar group).Stent migration and retrograde dissection occurred in 11 and 13 of all patients respectively, without significant differences between treatment approaches.36 patients underwent reintervention for proximal type i endoleak.One hundred of the 593 branch stents occluded.Of the 62 patients with branch occlusion, 28 were asymptomatic, and no reintervention performed.As of the bare metal stents used in f-tevar, the majority (26/27) were patent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMPLETE SE ILIAC
Type of Device
STENT, ILIAC
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
IE 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
IE  
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
IE  
091708734
MDR Report Key9665019
MDR Text Key177775258
Report Number9612164-2020-00554
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P090006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 02/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/20/2020
Initial Date FDA Received02/04/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age64 YR
-
-